Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
주식 순위 #7110
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
주가
$99.16
마지막 동기화: 2026-08-27
시가총액
$1.72B
변동 (1일)
0.00%
변동 (1년)
2.52%
국가
ES
거래 Pharma Mar, S.A. (PHM)

카테고리

Pharma Mar, S.A. (PHM)의 주식 분할 이력
Pharma Mar, S.A. 주식 (심볼: PHM)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 28, 2026에 발생했습니다.
Aug 28, 2026 이전에 매수한 PHM 주식 1주는 현재 0주의 PHM 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH